Literature DB >> 3038870

Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level.

M Laburthe, M Rousset, C Rouyer-Fessard, A Couvineau, I Chantret, G Chevalier, A Zweibaum.   

Abstract

The purpose of this work was to study vasoactive intestinal peptide (VIP) receptors and the adenylate cyclase response to VIP upon enterocytic differentiation of the human colon adenocarcinoma cell line Caco-2 in culture. The VIP-stimulated enzyme activity is very low, e.g. 20% above basal activity in undifferentiated cells (day 5) and is enhanced markedly at confluency reaching a maximum, e.g. 270%, above basal activity in fully differentiated cells (day 30). VIP potency is also slightly enhanced, the EC50 of VIP ranging from 0.31 nM at day 5 to 0.07 nM at day 30. Modifications of the adenylate cyclase system are not responsible for the development of VIP response. Indeed, forskolin-stimulated adenylate cyclase activity is unchanged during differentiation supporting no alteration of the enzyme catalytic subunit. The same holds true for NaF and guanosine 5'-(beta, gamma-imido)trisphosphate, indicating a constant activity of the guanine nucleotide regulatory unit which mediates hormonal stimulation of adenylate cyclase (Ns). This is further supported by the similar extent of cholera toxin-catalyzed [32P]ADP-ribosylation of the Ns protein that is observed during differentiation. In sharp contrast, a dramatic increase of VIP receptor concentration is observed ranging from 32 fmol/mg of protein at day 5 to 414 fmol/mg of protein at day 30. This is confirmed by affinity cross-linking experiments showing an increased specific incorporation of 125I-VIP in a major 66,000-dalton component during differentiation. A slight increase in receptor affinity is also observed during differentiation with Kd ranging from 0.39 nM at day 5 to 0.08 nM at day 30. These data indicate that one population of VIP receptors accumulates during Caco-2 cell differentiation, representing the crucial event in the development of adenylate cyclase response to the peptide.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038870

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy.

Authors:  L G Guijarro; A Couvineau; M S Rodriguez-Pena; M G Juarranz; N Rodriguez-Henche; E Arilla; M Laburthe; J C Prieto
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

2.  Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase promoter contains a CREB binding site that regulates cAMP action in Caco-2 cells.

Authors:  A Eggers; C Caudevilla; G Asins; F G Hegardt; D Serra
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

3.  Prostaglandins protect human intestinal cells against ethanol injury by stabilizing microtubules: role of protein kinase C and enhanced calcium efflux.

Authors:  A Banan; G S Smith; Y Deshpande; C L Rieckenberg; E R Kokoska; T A Miller
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

Review 4.  The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications.

Authors:  V Meunier; M Bourrié; Y Berger; G Fabre
Journal:  Cell Biol Toxicol       Date:  1995-08       Impact factor: 6.691

5.  Increased expression of apolipoprotein genes accompanies differentiation in the intestinal cell line Caco-2.

Authors:  S R Reisher; T E Hughes; J M Ordovas; E J Schaefer; S I Feinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

6.  Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption.

Authors:  L Mahraoui; A Rodolosse; A Barbat; E Dussaulx; A Zweibaum; M Rousset; E Brot-Laroche
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

7.  Distribution of vasoactive intestinal polypeptide and substance P receptors in human colon and small intestine.

Authors:  L Y Korman; H Sayadi; B Bass; T W Moody; J W Harmon
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

8.  Effect of vasoactive intestinal polypeptide on the release of serotonin from the in vitro vascularly perfused small intestine of guinea pig.

Authors:  H Schwörer; K Racké; H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

9.  The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.

Authors:  A Couvineau; J J Maoret; C Rouyer-Fessard; I Carrero; M Laburthe
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

10.  Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells.

Authors:  J F Beaulieu; A Quaroni
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.